Diagnóstico diferencial de las complicaciones víricas del paciente inmunodeprimido sin infección por el VIH

  1. Capote Huelva, Francisco Javier
Journal:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Year of publication: 2014

Issue Title: Enfermedades infecciosas (II): infecciones víricas

Series: 11

Issue: 50

Pages: 2982-2986

Type: Article

DOI: 10.1016/S0304-5412(14)70726-7 DIALNET GOOGLE SCHOLAR

More publications in: Medicine: Programa de Formación Médica Continuada Acreditado

Abstract

Transplants and the use of new drugs for cancer and autoimmune diseases are causing an increase in the number of immunocompromised patients. In addition to bacterial and fungal infections, viral infections are an important cause of morbidity and mortality in this group, but not enough attention is normally displayed in the differential diagnosis. Although it is easy to recognize VZV skin lesions, it is not the case with most viral infections, so if there is clinical suspicion should be used appropriate diagnostic methods (PCR, biopsy). Should be assessed: type of underlying disease, previous serological status, treatment given, chronological pattern involving well defined periods with possibility of delayed symptoms (PML, posttransplantation lymphoproliferative disorder) and the association of indirect effects.

Bibliographic References

  • Abdel Massih RC, Razonable RR. Human herpesvirus 6 infections after liver transplantation. World J Gastroenterol. 2009;15:2561-9.
  • Adeyi OA, Costa G, Abu-Elmagd KM, Wu T. Rotavirus infection in adult small intestine allografts: a clinicopathological study of a cohort of 23 patients. Am J Transplant. 2010;10:2683-9.
  • Ahmed R, Buckland M, Davies L, Halmagyi GM, Rogers SL, Oberste S. Enterovirus 71 meningoencephalitis complicating rituximab thera-py. J Neurol Sci. 2011;305:149-51.
  • Artz AS, Somerfield MR, Feld JJ, Giusti AF, Kramer BS, Sabichi AL. American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases. J Clin Oncol. 2010;28:3199-202.
  • Bennett SM, Broekema NM, Imperiale MJ. BK polyomavirus: emerging pathogen. Microbes Infect. 2012;14:672-83.
  • Echavarría M. Adenoviruses in immunocompromised hosts. Clin Microbiol Rev. 2008;21:704-15.
  • Emery V, Zuckerman M, Jackson G, Aitken C, Osman H, Pagliuca A. Management of cytomegalovirus infection in haemopoietic stem cell transplantation. Br J Haematol. 2013;162:25-39.
  • Falsey AR. Current management of parainfluenza pneumonitis in immunocompromised patients: a review. Infect Drug Resist. 2012;5:121-7
  • Florea AV, Ionescu DN, Melhem MF. Parvovirus B19 infection in the immunocompromised host. Arch Pathol Lab Med. 2007;131:799-804.
  • Haas LE, Thijsen SF, van Elden L, Heemstra KA. Human metapneumo virus in adults. Viruses. 2013;5:87-110.
  • Hynicka LM, Ensor CR. Prophylaxis and treatment of respiratory syncy-tial virus in adult immunocompromised patients. Ann Pharmacother. 2012;46:558-66.
  • Jacobs SE, Soave R, Shore TB, Satlin MJ, Schuetz AN, Magro C. Human rhinovirus infections of the lower respiratory tract in hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2013;15(5):474-86.
  • Keene DL, Legare C, Taylor E, Gallivan J, Cawthorn GM, Vu D. Monoclonal antibodies and progressive multifocal leukoencephalopathy. Can J Neurol Sci. 2011;38:565-71.
  • Krones E, Högenauer C. Diarrhea in the immunocompromised patient. Gastroenterol Clin North Am. 2012;41:677-701.
  • Mahale P, Kontoyiannis DP, Chemaly RF, Jiang Y, Hwang JP, Davila M. Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol. 2012;57:1177-85.
  • Matthes-Martin S, Feuchtinger T, Shaw PJ, Engelhard D, Hirsch HH, Cordonnier C. European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011). Transpl Infect Dis. 2012;14:555-63.
  • Miller GG, Dummer JS. Herpes simplex and varicella zoster viruses: forgotten but not gone. Am J Transplant. 2007;7:741-7
  • Pol S. Management of HBV in immunocompromised patients. Liver Int. 2013;33Suppl1:182-7.
  • Razonable RR, Zerr DM. HHV-6, HHV-7 and HHV-8 in solid organ transplant recipients. Am J Transplant. 2009;9Suppl4:S100-3.
  • Salavert M, Granada R, Díaz A, Zaragoza R. Role of viral infections in immunosuppressed patients. Med Intensiva. 2011;35:117-25.
  • Shah DP, Ghantoji SS, Mulanovich VE, Ariza-Heredia EJ, Chemaly RF. Management of respiratory viral infections in hematopoietic cell transplant recipients. Am J Blood Res. 2012;2:203-18.
  • Weikert BC, Blumberg EA. Viral infection after renal transplantation: surveillance and management. Clin J Am Soc Nephrol. 2008;3Suppl2:S76-86.
  • Zignego AL, Giannini C, Gragnani L, Piluso A, Fognani E. Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact. J Transl Med. 2012;10:158.
  • Zuckerman R, Wald A. Herpes simplex virus infections in solid organ transplant recipients. Am J Transplant. 2009;9Suppl4:S104-7
Data source: Dialnet